CAPR - Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences | Benzinga
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at various upcoming scientific and medical conferences.
| Event: |
| American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting (Baltimore, MD) |
| Date: |
| May 7–11, 2024 |
| Format: |
| Oral Presentation/Abstract: Exosome-mediated intracellular delivery of arginase-1: a potential application for the treatment of Arginase-1 Deficiency |
| Event: |
| Parent Project Muscular Dystrophy (PPMD) Cardiac Workshop III (Baltimore, MD) |
| Date: |
| May 9–10, 2024 |
| Format: |
| Panel: Industry perspectives on cardiac monitoring in DMD clinical trials |
| Event: |
| International Society of Extracellular Vesicles (ISEV) 2024 Meeting (Melbourne, Australia) |
| Date: |
| May 9–12, 2024 |
| Format: |
| Abstract: Targeted cargo delivery to mouse lower limb by exosomes carrying a muscle targeting moiety with intravenous injection |
| Event: |
| CureDuchenne 2024 FUTURES National Conference (Orlando, FL) |
| Date: |
| May 23–26, 2024 |
| Format: |
| Presentation: CAP-1002: an allogeneic cell ... |